Chronic gout is a painful condition caused by high levels of uric acid in the blood. Many patients continue to experience flare-ups even after using standard medications.
Krystexxa infusion is an advanced treatment designed for patients with severe or treatment-resistant gout. Unlike traditional medications, Krystexxa for gout works by breaking down uric acid in the body, helping reduce symptoms and prevent long-term joint damage. This Krystexxa treatment is given under medical supervision and is ideal for patients who have not responded to conventional therapies.
Krystexxa (pegloticase) is an FDA-approved treatment for adults with chronic gout that is not well controlled by other medications. It helps lower uric acid levels and reduce tophi, which are deposits of uric acid crystals under the skin.
This Krystexxa treatment is specifically used for patients with refractory gout who have not achieved target uric acid levels with standard therapies.
Krystexxa for gout is used to treat:
Krystexxa infusion therapy is given through an IV every two weeks by a healthcare professional. It works by converting uric acid into a harmless substance that is easily removed from the body.
Because Krystexxa for gout lowers uric acid quickly, some patients may experience temporary flare-ups early in treatment. Doctors may prescribe medications to reduce these flares.
Patients are tested before starting Krystexxa treatment to ensure safety.
Krystexxa treatment may be suitable for adults who have:
To reduce risks during Krystexxa infusion therapy, patients may receive:
Your first Krystexxa infusion is done in a monitored clinical setting. Most patients tolerate the treatment well. Medications may be given before the session to reduce the risk of reactions.
The Krystexxa cost varies depending on insurance coverage and individual treatment plans.
Common Krystexxa (pegloticase) side effects include:
All Krystexxa infusion therapy sessions are performed under medical supervision to ensure safety.
Krystexxa for gout is highly effective for patients with severe disease. It quickly lowers uric acid levels and helps improve joint health.
Patients may start seeing improvement within a few weeks of starting Krystexxa treatment, with better results over time.
Take control of your condition with expert Krystexxa infusion therapy.
✔ Personalized treatment
✔ Insurance support
✔ Safe clinical environment
📞 Call (+1 (480) 571-3060) or
Krystexxa for gout is used to treat chronic gout that does not respond to standard medications.
The Krystexxa cost depends on insurance and financial assistance programs.
Yes, many plans may cover Krystexxa treatment.
A Krystexxa infusion typically takes about 2 hours.
Krystexxa for gout helps manage severe gout by lowering uric acid levels.
Common Krystexxa side effects include gout flares, nausea, and infusion reactions.
